文献库，生知库 | 链接生命科学的每一步

日期影响因子

Radioembolization (90Y) achieves higher response rates and reduces progression risk compared with DEB-TACE in hepatocellular carcinoma

在肝细胞癌治疗中，与药物洗脱微球经导管动脉化疗栓塞术（DEB-TACE）相比，放射性栓塞术（90Y）可获得更高的缓解率并降低疾病进展风险。

期刊:Hepatology Communications

影响因子:4.6

doi:10.1097/HC9.0000000000000935

Núñez, Kelley; Hasani, Navid; Cronan, Julie; Gimenez, Juan; Cohen, Ari; Sandow, Tyler; Thevenot, Paul

细胞生物学

发表日期：2026

文献求助收藏

Contemporary Clinical Utilization of Radioembolization with Immune Checkpoint Inhibitors as First-Line Treatment in HCC: Real-World Report on Safety and Outcomes

免疫检查点抑制剂联合放射性栓塞作为肝细胞癌一线治疗的当代临床应用：安全性和疗效的真实世界报告

影响因子:4.4

doi:10.3390/cancers17172745

Núñez, Kelley G; Sandow, Tyler; Grahovac, Alexandre; Vallejo-Calzada, Ricardo; Gimenez, Juan; Bohorquez, Humberto; Cohen, Ari; Mizrahi, Jonathan; Du, Lingling; Thevenot, Paul

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Sustained AFP-L3 or DCP expression is associated with progression risk and inferior outcomes in unresectable hepatocellular carcinoma

持续的AFP-L3或DCP表达与不可切除肝细胞癌的进展风险和不良预后相关。

期刊:Clinical and Experimental Medicine

影响因子:3.5

doi:10.1007/s10238-025-01877-8

Núñez, Kelley; Sandow, Tyler; Burton, Jeff; Hibino, Mina; Gimenez, Juan; Cohen, Ari; Mehta, Neil; Thevenot, Paul

细胞生物学

发表日期：2025

文献求助收藏

PATH-02. Angiomyxofibromatous tumor of the falx cerebelli: a rare and unclassified intracranial lesion mimicking posterior fossa pathologies

PATH-02. 小脑镰血管黏液纤维瘤：一种罕见且未分类的颅内病变，可模拟后颅窝病变

期刊:Diagnostics

影响因子:3.3

doi:10.3390/diagnostics16010043

Young, Shamar; Naser-Tavakolian, Kiyon; Sajan, Abin; Reis, Stephen; Woodhead, Gregory; Sandow, Tyler; Gimenez, Juan; Garcia-Reyes, Kirema; Berman, Zachary; Krishnasamy, Venkatesh P; Modi, Parth; Rohra, Vinay; Patel, Parth; Kachchhi, Udayan

发表日期：2025

文献求助收藏

Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular Carcinoma

肝脏靶向治疗后影像学检查延迟会增加早期至中期肝细胞癌的进展风险

影响因子:4.4

doi:10.3390/cancers16010212

Stanneart, Jordin; Nunez, Kelley G; Sandow, Tyler; Gimenez, Juan; Fort, Daniel; Hibino, Mina; Cohen, Ari J; Thevenot, Paul T

细胞生物学

发表日期：2024

文献求助收藏

Yttrium-90 Induces an Effector Memory Response with Neoantigen Clonotype Expansion: Implications for Immunotherapy.

钇-90 诱导效应记忆反应并伴有新抗原克隆型扩增：对免疫疗法的意义

期刊:Cancer Research Communications

影响因子:3.3

doi:10.1158/2767-9764.CRC-24-0228

NÃºÃ±ez Kelley, Sandow Tyler, Gimenez Juan, Hibino Mina, Cohen Ari, Thevenot Paul

发表日期：2024

文献求助收藏

α-Fetoprotein, α-Fetoprotein-L3, and Des-γ-Carboxy Prothrombin Stratify Hepatocellular Carcinoma Treatment Response and Progression Risk

甲胎蛋白、甲胎蛋白-L3 和去羧基凝血酶原可对肝细胞癌的治疗反应和进展风险进行分层。

期刊:Gastro Hep Advances

doi:10.1016/j.gastha.2023.11.018

Núñez, Kelley; Schneider, Michael; Sandow, Tyler; Gimenez, Juan; Hibino, Mina; Fort, Daniel; Cohen, Ari; Thevenot, Paul

细胞生物学

发表日期：2024

文献求助收藏

PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival

肝细胞癌中PD-1的表达可预测肝脏靶向治疗的反应和移植过渡期的生存率。

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-021-03087-z

Núñez, Kelley G; Sandow, Tyler; Fort, Daniel; Hibino, Mina; Wright, Paige; Cohen, Ari J; Thevenot, Paul T

细胞生物学

发表日期：2022

文献求助收藏

Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant Candidates

低白蛋白血症是肝细胞癌的独立危险因素，是低风险移植桥接候选者肿瘤进展的危险因素。

影响因子:4.4

doi:10.3390/cancers14071684

Núñez, Kelley G; Sandow, Tyler; Patel, Jai; Hibino, Mina; Fort, Daniel; Cohen, Ari J; Thevenot, Paul

细胞生物学

发表日期：2022

文献求助收藏

Distinct Gene Expression Profiles in Viable Hepatocellular Carcinoma Treated With Liver-Directed Therapy

接受肝脏靶向治疗的存活肝细胞癌中存在独特的基因表达谱

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2022.809860

Núñez, Kelley G; Sandow, Tyler; Lakey, Meredith A; Fort, Daniel; Cohen, Ari J; Thevenot, Paul T

细胞生物学

发表日期：2022

文献求助收藏